(Total Views: 482)
Posted On: 03/30/2019 9:57:46 PM
Post# of 72436
we see ABSSSI as the appropriate gateway indication in infectious diseases, enabling potential further studies of Brilacidin's use for implant coating and biofilm infections.
BOOM!
BOOM!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)